The Uromigos Episode 165: Paper of the Month—ENZAMET Quality of Life Data

By The Uromigos - Last Updated: April 6, 2022

Martin Stockler describes the Enzalutamide in First-Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET) trial, which shows mixed effects of enza on QOL in prostate cancer.

Post Tags:Uromigos-Paper of the MonthUromigos-Prostate Cancer
Advertisement
Advertisement